the response rate after schedule vap ( vincristine , doxorubicin and prednisolone ) was 8 % of 13 patients and that after schedule vad ( vincristine , doxorubicin and dexamethasone ) 20 % of 59 patients .
C0077973
vad
C0011777
dexamethasone